Atlas Trials

Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)

Clinical trial NCT02954848 · COMPLETED

Trial details

NCT number
NCT02954848
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non-erosive Gastroesophageal Reflux Disease
Start date
2016-11-15
Primary completion
2018-02-25
Enrollment
484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.